/Companies

Hightidetx

1 known investors

Find your way into Hightidetx

Sign up to see every warm intro you have to Hightidetx

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Hightidetx team. We find them
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

HighTide Therapeutics is a biopharmaceutical company developing multifunctional therapies targeting cardiovascular-kidney-metabolic diseases. The company has a globally integrated pipeline with lead asset HTD1801 designated as a Fast Track and Orphan Drug candidate by the FDA.

Founders & leadership

LL
Liping LiuFounder, Chairwoman and CEO

Investors · 1

Frequently asked questions

What does Hightidetx do?
HighTide Therapeutics is a biopharmaceutical company developing multifunctional therapies targeting cardiovascular-kidney-metabolic diseases. The company has a globally integrated pipeline with lead asset HTD1801 designated as a Fast Track and Orphan Drug candidate by the FDA.
Who founded Hightidetx?
Hightidetx was founded by Liping Liu.
Who are Hightidetx's investors?
Hightidetx's investors include Blue Ocean Capital Group.